Nanomedicines and Vaccines
NANO-VAC
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (10)
2022
-
Consensus on the Definition of Control and Remission in Chronic Urticaria
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269
-
Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14
2021
-
Management of hypersensitivity reactions to chemotherapy and biologic agents: A survey of ARADyAL (Asthma, Adverse Drug Reactions and Allergy Network) Spanish allergy services
Allergy: European Journal of Allergy and Clinical Immunology
2019
-
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)
Health and Quality of Life Outcomes, Vol. 17, Núm. 1
-
Quality of Life in Patients with Allergic Reactions to Medications: Influence of a Drug Allergy Evaluation
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 8, pp. 2714-2721
-
Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348
2017
-
Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements
Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144
2015
-
Management of urticaria: Not too complicated, not too simple
Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743
2014
-
Assessment of severity and quality of life in chronic urticaria
Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 2, pp. 80-86
2013
-
Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice
Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228